Transbiohope | Biohope Poster awarded at 2019 ATC
Transbio project, oriented to the development of an in vitro diagnostic kit for the treatment of chronic rejection with immunosuppressants. H2020 program of the European Union
"trasplante riñón” “diagnóstico in vitro” “in vitro diagnosis” “trasplante renal” “H2020” “European Commission project” “renal transplant” “kidney transplant” “start-up” “Tres Cantos” “biomedicina” “biomedicine” “biotechnology” “immunobiogram” “inmunobiograma” “tratamiento inmunosupresores” “Treatment with immunosuppressants”
16311
post-template-default,single,single-post,postid-16311,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Biohope Poster awarded at 2019 ATC

Biohope Poster awarded at 2019 ATC

Our CEO Isabel Portero and medical director Teresa Díez are at ATC2019Boston presenting the results of BH-Pilot clinical study which demonstrate the use of Immunobiogram® in the personalization of immunosupresant therapy.  We are proud that our poster have been award-winner.

The American Transplant Congress is the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).  ATC provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation and brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals. The educational offerings provide attendees the opportunity to learn cutting-edge advances in research and exchange of ideas and practice in the field of solid organ and tissue transplantation.

The science of tomorrow starts today.

poster with BH-Pilot clinical study results